the beginning of 2004, µTBC products and customized product applications became available in the following areas:
- Metabolic Profiling µTBC for the detection of nephrotoxic and hepatotoxic target substances / metabolites of cardiovascular and oncology drugs
- Adverse Event Profiling µTBC for cardiovascular and oncology drugs as well as antibody-based biologicals
- Cardiovascular analytes available on request
Product and customer references available on request.